Diabetes mellitus and increased risk of cholangiocarcinoma: A meta-analysis

European Journal of Cancer Prevention

Volumn 21, Issue 1, 2012, Pages 24-31

  Jing, Wei ^a   Jin, Gang ^a   Zhou, Xuyu ^a   Zhou, Yingqi ^a   Zhang, Yijie ^a   Shao, Chenghao ^a   Liu, Rui ^a   Hu, Xiangui ^a  

^a SECOND MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

Cholangiocarcinoma; Diabetes mellitus; Extrahepatic cholangiocarcinoma; Intrahepatic cholangiocarcinoma; Meta analysis

Indexed keywords

ARTICLE; BILE DUCT CARCINOMA; CANCER REGISTRY; CANCER RISK; CASE CONTROL STUDY; DIABETES MELLITUS; DISEASE ASSOCIATION; EMBASE; EXTRAHEPATIC CHOLANGIOCARCINOMA; GEOGRAPHIC DISTRIBUTION; HUMAN; INTRAHEPATIC CHOLANGIOCARCINOMA; MEDLINE; PRIORITY JOURNAL;

BILE DUCT NEOPLASMS; BILE DUCTS, INTRAHEPATIC; CASE-CONTROL STUDIES; CHOLANGIOCARCINOMA; DIABETES COMPLICATIONS; DIABETES MELLITUS; HUMANS; RISK FACTORS;

EID: 82555172378     PISSN: 09598278     EISSN: 14735709     Source Type: Journal    
DOI: 10.1097/CEJ.0b013e3283481d89     Document Type: Article

References (54)

1. Adami HO, McLaughlin J, Ekbom A, Berne C, Silverman D, Hacker D, et al. (1991). Cancer risk in patients with diabetes mellitus. Cancer Causes Control 2:307-314.
2. Adami HO, Chow WH, Nyren O, Berne C, Linet MS, Ekbom A, et al. (1996). Excess risk of primary liver cancer in patients with diabetes mellitus. J Natl Cancer Inst 88:1472-1477. (Pubitemid 26340049)
3. Alvaro D, Barbaro B, Franchitto A, Onori P, Glaser SS, Alpini G, et al. (2006). Estrogens and insulin-like growth factor 1 modulate neoplastic cell growth in human cholangiocarcinoma. Am J Pathol 169:877-888. (Pubitemid 44411954)
4. Begg CB, Mazumdar M (1994). Operating characteristics of a rank correlation test for publication bias. Biometrics 50:1088-1101.
5. Ben Q, Cai Q, Li Z, Yuan Y, Ning X, Deng S, et al. (2011). The relationship between new-onset diabetes mellitus and pancreatic cancer risk: a casecontrol study. Eur J Cancer 47:248-254.
6. Biddinger SB, Haas JT, Yu BB, Bezy O, Jing E, Zhang W, et al. (2008). Hepatic insulin resistance directly promotes formation of cholesterol gallstones. Nat Med 14:778-782.
7. Cai HH, Sun YM, Bai JF, Shi Y, Zhao HL, Miao Y (2008). Relationship between the GH-IGFs axis and the proliferation of bile duct cancer cell line QBC939 in vitro. Hepatobiliary Pancreat Dis Int 7:76-81. (Pubitemid 351247061)
8. Calle EE, Kaaks R (2004). Overweight, obesity and cancer: epidemiological evidence and proposed mechanisms. Nat Rev Cancer 4:579-591. (Pubitemid 39025053)
9. Chen CL, Yang HI, Yang WS, Liu CJ, Chen PJ, You SL, et al. (2008). Metabolic factors and risk of hepatocellular carcinoma by chronic hepatitis B/C infection: a follow-up study in Taiwan. Gastroenterology 135:111-121.
10. Claessen MM, Vleggaar FP, Tytgat KM, Siersema PD, van Buuren HR (2009). High lifetime risk of cancer in primary sclerosing cholangitis. J Hepatol 50:158-164.
11. DerSimonian R, Laird N (1986). Meta-analysis in clinical trials. Control Clin Trials 7:177-188. (Pubitemid 17189972)
12. Egger M, Davey Smith G, Schneider M, Minder C (1997). Bias in meta-analysis detected by a simple, graphical test. BMJ 315:629-634. (Pubitemid 27387172)
13. El-Serag HB, Hampel H, Javadi F (2006). The association between diabetes and hepatocellular carcinoma: a systematic review of epidemiologic evidence. Clin Gastroenterol Hepatol 4:369-380. (Pubitemid 43343895)
14. El-Serag HB, Engels EA, Landgren O, Chiao E, Henderson L, Amaratunge HC, et al. (2009). Risk of hepatobiliary and pancreatic cancers after hepatitis C virus infection: a population-based study of US veterans. Hepatology 49:116-123.
15. Erichsen R, Jepsen P, Vilstrup H, Ekbom A, Sorensen HT (2009). Incidence and prognosis of cholangiocarcinoma in Danish patients with and without inflammatory bowel disease: a national cohort study, 1978-2003. Eur J Epidemiol 24:513-520.
16. Festi D, Dormi A, Capodicasa S, Staniscia T, Attili AF, Loria P, et al. (2008). Incidence of gallstone disease in Italy: results from a multicenter, population-based Italian study (the MICOL project). World J Gastroenterol 14:5282-5289.
17. Frasca F, Pandini G, Sciacca L, Pezzino V, Squatrito S, Belfiore A, et al. (2008). The role of insulin receptors and IGF-I receptors in cancer and other diseases. Arch Physiol Biochem 114:23-37. (Pubitemid 351998752)
18. Gallagher EJ, Fierz Y, Ferguson RD, LeRoith D (2010). The pathway from diabetes and obesity to cancer, on the route to targeted therapy. Endocr Pract 16:864-873.
19. Gapstur SM, Gann PH, Lowe W, Liu K, Colangelo L, Dyer A (2000). Abnormal glucose metabolism and pancreatic cancer mortality. JAMA 283:2552-2558. (Pubitemid 30324198)
20. Grainge MJ, West J, Solaymani-Dodaran M, Aithal GP, Card TR (2009). The antecedents of biliary cancer: a primary care case-control study in the United Kingdom. Br J Cancer 100:178-180.
21. Heidemann C, Boeing H, Pischon T, Nothlings U, Joost HG, Schulze MB (2009). Association of a diabetes risk score with risk of myocardial infarction, stroke, specific types of cancer, and mortality: a prospective study in the European Prospective Investigation into Cancer and Nutrition (EPIC)-Potsdam cohort. Eur J Epidemiol 24:281-288.
22. Hemminki K, Li X, Sundquist J, Sundquist K (2010). Risk of cancer following hospitalization for type 2 diabetes. Oncologist 15:548-555.
23. Higgins JP, Thompson SG (2002). Quantifying heterogeneity in a meta-analysis. Stat Med 21:1539-1558. (Pubitemid 34746062)
24. Hou L, Xu J, Gao YT, Rashid A, Zheng SL, Sakoda LC, et al. (2006). CYP17 MspA1 polymorphism and risk of biliary tract cancers and gallstones: a population-based study in Shanghai, China. Int J Cancer 118:2847-2853. (Pubitemid 43673366)
25. Hsing AW, Zhang M, Rashid A, McGlynn KA, Wang BS, Niwa S, et al. (2008). Hepatitis B and C virus infection and the risk of biliary tract cancer: a population-based study in China. Int J Cancer 122:1849-1853. (Pubitemid 351413433)
26. Jamal MM, Yoon EJ, Vega KJ, Hashemzadeh M, Chang KJ (2009). Diabetes mellitus as a risk factor for gastrointestinal cancer among American veterans. World J Gastroenterol 15:5274-5278.
27. Jee SH, Ohrr H, Sull JW, Yun JE, Ji M, Samet JM (2005). Fasting serum glucose level and cancer risk in Korean men and women. JAMA 293:194-202. (Pubitemid 40095870)
28. Khan SA, Thomas HC, Davidson BR, Taylor-Robinson SD (2005). Cholangiocarcinoma. Lancet 366:1303-1314. (Pubitemid 41416587)
29. Khan M, Mori M, Fujino Y, Shibata A, Sakauchi F, Washio M, et al. (2006). Sitespecific cancer risk due to diabetes mellitus history: evidence from the Japan Collaborative Cohort (JACC) Study. Asian Pac J Cancer Prev 7:253-259.
30. Larsson SC,Wolk A (2007). Obesity and the risk of gallbladder cancer: a metaanalysis. Br J Cancer 96:1457-1461. (Pubitemid 46685777)
31. Lazaridis KN, Gores GJ (2005). Cholangiocarcinoma. Gastroenterology 128:1655-1667. (Pubitemid 40692558)
32. Lee TY, Lee SS, Jung SW, Jeon SH, Yun SC, Oh HC, et al. (2008). Hepatitis B virus infection and intrahepatic cholangiocarcinoma in Korea: a case-control study. Am J Gastroenterol 103:1716-1720.
33. Levine AJ, Feng Z, Mak TW, You H, Jin S (2006). Coordination and communication between the p53 and IGF-1-AKT-TOR signal transduction pathways. Genes Dev 20:267-275. (Pubitemid 43200281)
34. Li D, Abbruzzese JL (2010). New strategies in pancreatic cancer: emerging epidemiologic and therapeutic concepts. Clin Cancer Res 16:4313-4318.
35. Lin SY, Hsieh MS, Chen LS, Chiu YH, Yen AM, Chen TH (2007). Diabetes mellitus associated with the occurrence and prognosis of non-Hodgkin's lymphoma. Eur J Cancer Prev 16:471-478. (Pubitemid 47550009)
36. Nathan H, Pawlik TM,Wolfgang CL, Choti MA, Cameron JL, Schulick RD (2007). Trends in survival after surgery for cholangiocarcinoma: a 30-year populationbased SEER database analysis. J Gastrointest Surg 11:1488-1496 [discussion 1496-1487].
37. Patel T (2001). Increasing incidence and mortality of primary intrahepatic cholangiocarcinoma in the United States. Hepatology 33:1353-1357. (Pubitemid 32496970)
38. Saltzman BS, Doherty JA, Hill DA, Beresford SA, Voigt LF, Chen C, et al. (2008). Diabetes and endometrial cancer: an evaluation of the modifying effects of other known risk factors. Am J Epidemiol 167:607-614. (Pubitemid 351323306)
39. Samani AA, Yakar S, LeRoith D, Brodt P (2007). The role of the IGF system in cancer growth and metastasis: overview and recent insights. Endocr Rev 28:20-47. (Pubitemid 46220849)
40. Shaib YH, Davila JA, McGlynn K, El-Serag HB (2004). Rising incidence of intrahepatic cholangiocarcinoma in the United States: a true increase? J Hepatol 40:472-477. (Pubitemid 38230849)
41. Shaib YH, El-Serag HB, Davila JA, Morgan R, McGlynn KA (2005). Risk factors of intrahepatic cholangiocarcinoma in the United States: a case-control study. Gastroenterology 128:620-626. (Pubitemid 40585364)
42. Shaib YH, El-Serag HB, Nooka AK, Thomas M, Brown TD, Patt YZ, et al. (2007). Risk factors for intrahepatic and extrahepatic cholangiocarcinoma: a hospitalbased case-control study. Am J Gastroenterol 102:1016-1021. (Pubitemid 46698225)
43. Shebl FM, Andreotti G, Rashid A, Gao YT, Yu K, Shen MC, et al. (2010). Diabetes in relation to biliary tract cancer and stones: a population-based study in Shanghai, China. Br J Cancer 103:115-119.
44. Stone BG, Van Thiel DH (1985). Diabetes mellitus and the liver. Semin Liver Dis 5:8-28.
45. Tao LY, He XD, Qu Q, Cai L, Liu W, Zhou L, et al. (2010). Risk factors for intrahepatic and extrahepatic cholangiocarcinoma: a case-control study in China. Liver Int 30:215-221.
46. Vauthey JN, Blumgart LH (1994). Recent advances in the management of cholangiocarcinomas. Semin Liver Dis 14:109-114. (Pubitemid 24153079)
47. Welzel TM, McGlynn KA, Hsing AW, O'Brien TR, Pfeiffer RM (2006a). Impact of classification of hilar cholangiocarcinomas (Klatskin tumors) on the incidence of intra- and extrahepatic cholangiocarcinoma in the United States. J Natl Cancer Inst 98:873-875. (Pubitemid 43923444)
48. Welzel TM, Mellemkjaer L, Gloria G, Sakoda LC, Hsing AW, El Ghormli L, et al. (2006b). Risk factors for intrahepatic cholangiocarcinoma in a low-risk population: a nationwide case-control study. Int J Cancer 120:638-641.
49. Welzel TM, Graubard BI, El-Serag HB, Shaib YH, Hsing AW, Davila JA, et al. (2007). Risk factors for intrahepatic and extrahepatic cholangiocarcinoma in the United States: a population-based case-control study. Clin Gastroenterol Hepatol 5:1221-1228. (Pubitemid 47496233)
50. Werner H,Weinstein D, Yehezkel E, Laron Z (2011). Controversies in the use of insulin analogues. Expert Opin Biol Ther 11:199-209.
51. Yamamoto S, Kubo S, Hai S, Uenishi T, Yamamoto T, Shuto T, et al. (2004). Hepatitis C virus infection as a likely etiology of intrahepatic cholangiocarcinoma. Cancer Sci 95:592-595. (Pubitemid 39089641)
52. Yang W, Lu J, Weng J, Jia W, Ji L, Xiao J, et al. (2010). Prevalence of diabetes among men and women in China. N Engl J Med 362:1090-1101.
53. Zhou YM, Yin ZF, Yang JM, Li B, Shao WY, Xu F, et al. (2008). Risk factors for intrahepatic cholangiocarcinoma: a case-control study in China. World J Gastroenterol 14:632-635. (Pubitemid 351320834)
54. Zimmet P, Alberti KG, Shaw J (2001). Global and societal implications of the diabetes epidemic. Nature 414:782-787. (Pubitemid 34000780)